Literature DB >> 8765164

Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit Poisson assumption.

T Bonnefoix1, P Bonnefoix, P Verdiel, J J Sotto.   

Abstract

Limiting dilution analysis is a common technique that is used in immunology to estimate accurately the frequency of cells possessing a wide variety of functional activities such as growth, cytotoxicity and production of lymphokines. The reliability of the estimated frequency is usually checked by a standard chi-square (x2) test validating the goodness-of-fit to the single-hit Poisson model (SHPM). We present evidence that modelling limiting dilution data according to a generalized linear model offers an alternative to the standard x2 test for detecting departures from the SHPM, with a considerable increase in power compared to the x2 test.

Entities:  

Mesh:

Year:  1996        PMID: 8765164     DOI: 10.1016/0022-1759(96)00077-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  31 in total

1.  An anti-CD45RO immunotoxin kills HIV-latently infected cells from individuals on HAART with little effect on CD8 memory.

Authors:  J Saavedra-Lozano; Y Cao; J Callison; R Sarode; D Sodora; J Edgar; J Hatfield; L Picker; D Peterson; O Ramilo; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

2.  A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.

Authors:  Benjamin T Spike; Dannielle D Engle; Jennifer C Lin; Samantha K Cheung; Justin La; Geoffrey M Wahl
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

3.  Radioresistance mechanisms of mammary tumor initiating cells: unreliable biological conclusions based on limiting dilution assays.

Authors:  Thierry Bonnefoix; Mary Callanan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

4.  Natural killer-cell differentiation by myeloid progenitors.

Authors:  Bartosz Grzywacz; Nandini Kataria; Niketa Kataria; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2010-12-20       Impact factor: 22.113

Review 5.  The emerging picture of the mouse mammary stem cell.

Authors:  François Vaillant; Marie-Liesse Asselin-Labat; Mark Shackleton; Geoffrey J Lindeman; Jane E Visvader
Journal:  Stem Cell Rev       Date:  2007-06       Impact factor: 5.739

6.  Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function.

Authors:  Adam C Pond; Xue Bin; Torey Batts; Kevin Roarty; Susan Hilsenbeck; Jeffrey M Rosen
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

7.  Zebrafish as a model for cancer self-renewal.

Authors:  Myron S Ignatius; David M Langenau
Journal:  Zebrafish       Date:  2009-12       Impact factor: 1.985

8.  Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity.

Authors:  Garrett G Muramoto; J Lauren Russell; Rachid Safi; Alice B Salter; Heather A Himburg; Pamela Daher; Sarah K Meadows; Phuong Doan; Robert W Storms; Nelson J Chao; Donald P McDonnell; John P Chute
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

9.  High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia.

Authors:  Alexandra C H Smith; Aubrey R Raimondi; Chris D Salthouse; Myron S Ignatius; Jessica S Blackburn; Igor V Mizgirev; Narie Y Storer; Jill L O de Jong; Aye T Chen; Yi Zhou; Sergei Revskoy; Leonard I Zon; David M Langenau
Journal:  Blood       Date:  2010-01-07       Impact factor: 22.113

10.  CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland.

Authors:  Heather L LaMarca; Adriana P Visbal; Chad J Creighton; Hao Liu; Yiqun Zhang; Fariba Behbod; Jeffrey M Rosen
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.